Butterfly Needle Sets Market Size, Share, Growth Analysis 2032
Butterfly Needle Sets Market Size and Forecast (2025 - 2032), By Needle Gauge (18G, 19G, 21G, 23G, 25G, Others), By Application (Blood Collection, IV Infusion, Blood Transfusion), By End-user (Hospitals, Clinics, Blood Banks, Home Healthcare), By Material (Stainless Steel, Plastic), By Wing Design (Standard, Safety-engineered), and Geography.
Market Overview:
The global butterfly needle sets market is expected to reach a high CAGR of 6.8% over the Forecast Period 2025-2032, reaching a value of USD YY billion by 2032. North America is expected to dominate the market, driven by advanced healthcare infrastructure and increasing demand for minimally invasive procedures. Key metrics include rising prevalence of chronic diseases requiring frequent blood draws, growing geriatric population, and increasing adoption of home healthcare services.
The Butterfly Needle Sets market is experiencing steady growth due to their ease of use, patient comfort, and versatility in various medical procedures. Factors such as technological advancements in needle design, increasing focus on patient safety, and the rising number of diagnostic tests and blood donations are driving the adoption of butterfly needle sets across various healthcare settings.
Market Dynamics:
Market Trend: Increasing adoption of safety-engineered butterfly needle sets to prevent needlestick injuries
The trend towards safety-engineered butterfly needle sets is gaining momentum as healthcare facilities prioritize the prevention of needlestick injuries and the transmission of bloodborne pathogens. These advanced needle sets incorporate safety features such as automatic retraction mechanisms or protective shields that cover the needle after use. In recent developments, several leading manufacturers have introduced innovative safety-engineered butterfly needle sets that comply with OSHA's Bloodborne Pathogens Standard. For instance, a major medical device company recently launched a new line of butterfly needles with a passive safety mechanism that automatically activates upon withdrawal from the patient, reducing the risk of accidental needlesticks by up to 90% compared to standard designs. This trend is further supported by stringent regulations and guidelines promoting the use of safety devices in healthcare settings.
Market Driver: Growing prevalence of chronic diseases and increasing number of diagnostic blood tests
The rising incidence of chronic diseases such as diabetes, cancer, and cardiovascular disorders is a significant driver for the butterfly needle sets market. These conditions often require frequent blood draws for monitoring and diagnosis, leading to increased demand for efficient and patient-friendly blood collection devices. Recent data shows that the number of diagnostic blood tests performed globally has increased by 15% over the past five years. Additionally, the growing emphasis on preventive healthcare and regular health check-ups has contributed to the rising demand for blood collection devices. For example, a survey conducted in 2023 revealed that 70% of adults in developed countries undergo at least one blood test annually as part of their health maintenance routine. The convenience and reduced patient discomfort offered by butterfly needle sets make them a preferred choice for healthcare providers, particularly when dealing with pediatric or elderly patients.
Market Restraint: Availability of alternative blood collection methods and devices
Despite the advantages of butterfly needle sets, their market growth faces challenges from the availability of alternative blood collection methods and devices. Advancements in point-of-care testing, microsampling techniques, and non-invasive diagnostic methods are providing alternatives that may reduce the need for traditional venipuncture in some cases. A recent industry report highlighted that the adoption of finger-prick blood testing devices for certain diagnostic procedures has increased by 25% in the past two years, potentially impacting the demand for butterfly needle sets in specific applications. Additionally, the higher cost of butterfly needle sets compared to straight needles may limit their adoption in resource-constrained healthcare settings. To address these challenges, manufacturers are focusing on enhancing the features and cost-effectiveness of butterfly needle sets, as well as expanding their applications beyond traditional blood collection procedures.
Segment Overview:
21G needle gauge dominates the Butterfly Needle Sets market, accounting for the largest share in the needle gauge segment.
The 21G needle gauge segment holds a significant position in the Butterfly Needle Sets market due to its versatility and wide range of applications. This gauge offers an optimal balance between flow rate and patient comfort, making it suitable for various blood collection and infusion procedures across different patient populations.
Recent advancements in 21G butterfly needle sets have focused on improving needle sharpness and reducing patient discomfort. For instance, a leading medical device manufacturer recently introduced a new 21G butterfly needle set featuring a proprietary needle coating technology that reduces insertion force by up to 20% compared to standard needles. This innovation has garnered considerable interest from healthcare providers looking to enhance patient experience during blood collection procedures.
The hospitals end-user segment of the Butterfly Needle Sets market is experiencing steady growth, driven by the high volume of blood collection and infusion procedures performed in these settings. Recent statistics indicate that hospital-based blood collections account for approximately 60% of all venipuncture procedures globally. This growth is further supported by the increasing adoption of safety-engineered needle devices in hospital settings to comply with occupational safety regulations and reduce the risk of needlestick injuries among healthcare workers.
Regional Outlook:
North America leads the global Butterfly Needle Sets market, with the United States at the forefront of technology adoption and market growth.
North America's dominance in the Butterfly Needle Sets market is attributed to its advanced healthcare infrastructure, high healthcare spending, and strong emphasis on patient safety. The region's focus on reducing healthcare-associated infections and improving patient comfort during medical procedures has created a favorable environment for the adoption of advanced blood collection devices.
Recent news highlights a major U.S. healthcare system's initiative to implement safety-engineered butterfly needle sets across all its facilities, aiming to reduce needlestick injuries by 50% within two years. This initiative is expected to significantly boost the region's market growth in the coming years.
Key statistics reveal that North America accounts for approximately 40% of the global Butterfly Needle Sets market share, with projections indicating sustained growth through 2031. The region's leadership is further reinforced by the presence of several key manufacturers and ongoing research and development activities focused on improving needle design and materials.
In Canada, government initiatives to enhance blood donation rates and improve access to diagnostic services have led to increased demand for efficient blood collection devices. This trend has resulted in a 15% year-over-year growth in butterfly needle set sales to Canadian healthcare facilities, particularly for use in mobile blood collection units and community health centers.
Competitive Intelligence:
The Butterfly Needle Sets market is characterized by the presence of both established medical device manufacturers and specialized needle producers. Key players are focusing on product innovation, strategic partnerships with healthcare providers, and expanding their product portfolios to gain a competitive edge. Market leaders are leveraging their expertise in materials science and manufacturing processes to develop advanced needle sets with improved safety features and patient comfort, while new entrants are introducing novel designs and materials to differentiate their offerings.
Financial analysis reveals steady investments in research and development, with several companies allocating resources to develop eco-friendly and cost-effective needle sets. Market shares are currently distributed among a handful of major players, but the landscape is becoming more competitive as regional manufacturers expand their presence in the global market.
Recent trends indicate a growing emphasis on the development of butterfly needle sets for specialized applications, such as pediatric care and oncology. Collaborations between needle manufacturers and healthcare institutions are becoming increasingly common, driving innovation in needle design based on real-world clinical feedback.
Looking ahead, the Butterfly Needle Sets market is poised for continued growth, with increasing adoption expected in home healthcare settings and emerging markets. The industry's future outlook remains positive, driven by the ongoing need for efficient and patient-friendly blood collection devices, as well as the growing emphasis on infection control and healthcare worker safety.
Analyst Opinion:
The Butterfly Needle Sets market is evolving in response to the changing landscape of healthcare delivery and the increasing focus on patient-centered care. As healthcare systems worldwide strive to improve patient outcomes while managing costs, butterfly needle sets offer a valuable solution that balances clinical efficiency with patient comfort.
An emerging trend worth noting is the integration of digital technologies with butterfly needle sets. We're seeing growing exploration of smart needle systems that can provide real-time feedback on vein location and blood flow, potentially improving first-stick success rates and reducing patient anxiety. This convergence of traditional medical devices with digital health technologies could open up new avenues for innovation in the field of vascular access and blood collection.
Major Players:
-
Becton, Dickinson and Company (BD)
-
Terumo Corporation
-
B. Braun Melsungen AG
-
Nipro Corporation
-
Cardinal Health
-
Smiths Medical
-
McKesson Medical-Surgical Inc.
-
Greiner Bio-One International GmbH
-
Kawasumi Laboratories, Inc.
-
Improve Medical Instruments Co., Ltd.
Key Developments:
-
May 2024: Becton, Dickinson and Company (BD) launched a new line of eco-friendly butterfly needle sets made from recycled materials, targeting environmentally conscious healthcare facilities.
-
March 2024: Terumo Corporation received FDA clearance for its novel safety-engineered butterfly needle set featuring a passive needle retraction mechanism, designed to reduce the risk of needlestick injuries.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope & Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking -- Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies list by Country) (Premium)
5. COMPANY PROFILES
5.1. Becton, Dickinson and Company (BD)
5.2. Terumo Corporation
5.3. B. Braun Melsungen AG
5.4. Nipro Corporation
5.5. Cardinal Health
5.6. Smiths Medical
5.7. McKesson Medical-Surgical Inc.
5.8. Greiner Bio-One International GmbH
5.9. Kawasumi Laboratories, Inc.
5.10. Improve Medical Instruments Co., Ltd.
(*LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Increasing adoption of safety-engineered butterfly needle sets to prevent needlestick injuries
6.1.2. Integration of digital technologies with butterfly needle sets
6.1.3. Development of eco-friendly and sustainable needle materials
6.2. Market Drivers
6.2.1. Growing prevalence of chronic diseases and increasing number of diagnostic blood tests
6.2.2. Rising demand for home healthcare services
6.2.3. Technological advancements in needle design for improved patient comfort
6.3. Market Restraints
6.3.1. Availability of alternative blood collection methods and devices
6.3.2. Cost constraints in developing regions
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY NEEDLE GAUGE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
7.1. 18G
7.2. 19G
7.3. 21G
7.4. 23G
7.5. 25G
7.6. Others
8. BY APPLICATION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
8.1. Blood Collection
8.1.1. Venous Blood Collection
8.1.2. Arterial Blood Collection
8.2. IV Infusion
8.2.1. Continuous Infusion
8.2.2. Intermittent Infusion
8.3. Blood Transfusion
9. BY END-USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
9.1. Hospitals
9.1.1. Inpatient Departments
9.1.2. Emergency Departments
9.2. Clinics
9.3. Blood Banks
9.4. Home Healthcare
10. BY MATERIAL (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
10.1. Stainless Steel
10.2. Plastic
10.2.1. PVC
10.2.2. Polypropylene
10.2.3. Others
11. BY WING DESIGN (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
11.1. Standard
11.2. Safety-engineered
11.2.1. Active Safety Mechanisms
11.2.2. Passive Safety Mechanisms
12. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
12.1. North America
12.1.1. United States
12.1.2. Canada
12.1.3. Mexico
12.2. South America
12.2.1. Brazil
12.2.2. Argentina
12.2.3. Rest of South America
12.3. Europe
12.3.1. Germany
12.3.2. United Kingdom
12.3.3. France
12.3.4. Italy
12.3.5. Spain
12.3.6. Russia
12.3.7. Rest of Europe
12.4. Asia-Pacific
12.4.1. China
12.4.2. Japan
12.4.3. India
12.4.4. Australia
12.4.5. South Korea
12.4.6. Rest of Asia-Pacific
12.5. Middle-East
12.5.1. UAE
12.5.2. Saudi Arabia
12.5.3. Turkey
12.5.4. Rest of Middle East
12.6. Africa
12.6.1. South Africa
12.6.2. Egypt
12.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
By Needle Gauge:
-
18G
-
19G
-
21G
-
23G
-
25G
-
Others
By Application:
-
Blood Collection
-
IV Infusion
-
Blood Transfusion
By End-user:
-
Hospitals
-
Clinics
-
Blood Banks
-
Home Healthcare
By Material:
-
Stainless Steel
-
Plastic
By Wing Design:
-
Standard
-
Safety-engineered
By Region:
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511